Search

Insulet Corp

Slēgts

SektorsVeselības aprūpe

142.58 -1.96

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

145.07

Max

150.86

Galvenie mērījumi

By Trading Economics

Ienākumi

3.9M

95M

Pārdošana

40M

802M

P/E

Sektora vidējais

26.21

57.371

EPS

1.66

Peļņas marža

11.85

Darbinieki

5,400

EBITDA

-22M

132M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+19.96% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 5. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-2.1B

9.7B

Iepriekšējā atvēršanas cena

144.54

Iepriekšējā slēgšanas cena

142.58

Ziņu noskaņojums

By Acuity

64%

36%

303 / 340 Rangs Healthcare

Insulet Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 24. aug. 19:56 UTC

News

Insulet Corp shares are lower amid negative sentiment from two class action lawsuits alleging securities fraud related to product safety concerns.

2026. g. 21. aug. 19:56 UTC

Insulet Corp shares are higher today, reflecting positive market momentum. Broader market gains, particularly in cryptocurrency, contribute to the stock's upward movement.

2026. g. 20. aug. 23:11 UTC

Insulet Corp shares are trading lower in after-market hours, continuing a decline that follows a reversal from earlier highs. No specific news was identified.

2026. g. 19. aug. 23:01 UTC

Insulet Corp shares are higher in after-market trading, continuing a trend of gains over the last three sessions without any specific news driving the movement.

2026. g. 18. aug. 20:03 UTC

Insulet Corp's shares are higher today, having previously peaked before pulling back. The stock has advanced since Monday's close, despite no specific news.

2026. g. 17. aug. 20:06 UTC

News

Insulet Corp shares are lower amid a class action lawsuit alleging securities law violations related to safety risks in manufacturing processes.

2026. g. 14. aug. 20:06 UTC

News

Insulet Corp faces a securities fraud class action lawsuit from Levi & Korsinsky, LLP, contributing to a decline in shares during regular trading hours.

2026. g. 13. aug. 23:06 UTC

Insulet Corp shares are lower in after-market hours, with no specific news identified to explain the decline. The stock remains near the middle of its one-month range.

2026. g. 12. aug. 19:36 UTC

Insulet Corp shares are higher during Wednesday's session, recovering from earlier lows. Broader market inflation data may be supporting positive sentiment.

2026. g. 11. aug. 19:46 UTC

Insulet Corp's shares are higher, continuing a four-session trend, despite no specific news. Market participants are reacting to recent economic indicators and Fed rate expectations.

2026. g. 10. aug. 22:56 UTC

News

Insulet Corp shares are lower in after-market trading following a class action lawsuit from Pomerantz LLP alleging false statements about manufacturing practices and product safety.

2026. g. 7. aug. 19:36 UTC

News

Insulet Corp shares are higher as Deutsche Bank initiates coverage with a "buy" rating and a $190 price target, despite a downgrade from Oppenheimer.

2026. g. 6. aug. 23:32 UTC

News

Insulet Corp shares are lower in after-market hours following a downgrade to Market Perform by Leerink Partners and a reduced price target of $145.

2026. g. 5. aug. 23:46 UTC

Insulet Corp. shares traded lower in after-market hours, reflecting routine activity and cautious market sentiment amid disappointing private sector employment data.

2026. g. 4. aug. 23:56 UTC

Insulet Corp shares are lower in after-market hours, showing little change since Tuesday's close amid a lack of specific company news.

2026. g. 3. aug. 19:36 UTC

Correlated Moves

Insulet Corp's shares are higher today, supported by a positive trend in the medical devices sector. The stock remains above its 20-day moving average.

2026. g. 31. jūl. 20:06 UTC

News

Insulet Corp shares are declining amid a securities class action lawsuit alleging misrepresentations about the safety of its Omnipod products.

2026. g. 29. jūl. 18:43 UTC

Insulet Corp shares are higher, driven by gains in the Health Care Equipment sub-sector. The stock remains well above its 20-day moving average.

2026. g. 28. jūl. 19:06 UTC

Correlated Moves

Insulet Corp shares are trading higher, benefiting from a significant rise in the Health Care Equipment sub-sector and ongoing momentum above their 20-day moving average.

2026. g. 27. jūl. 20:06 UTC

Insulet Corp shares are higher today, reflecting broader market trends despite an earlier pullback from a session high. No specific news was identified.

2026. g. 24. jūl. 22:26 UTC

Insulet Corp shares are lower in after-market hours, following a decline from earlier session lows. No specific company news was identified to explain the movement.

2026. g. 22. jūl. 20:01 UTC

News

Insulet Corp shares are lower amid a class action lawsuit alleging securities fraud related to safety claims about its Omnipod products.

2026. g. 20. jūl. 18:36 UTC

News

Insulet Corp is gaining today after being identified as a healthcare stock likely to deliver sustainable market-beating returns, despite ongoing legal challenges.

Salīdzinājums

Cenas izmaiņa

Insulet Corp Prognoze

Cenas mērķis

By TipRanks

19.96% augšup

Prognoze 12 mēnešiem

Vidējais 174.45 USD  19.96%

Augstākais 216 USD

Zemākais 144 USD

Pamatojoties uz 23 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Insulet Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

23 ratings

13

Pirkt

9

Turēt

1

Pārdot

Noskaņojums

By Acuity

303 / 340 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
help-icon Live chat